Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
4
Filing Date
3/4/2025
Updated
3/5/25, 2:22 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership